Thanks for Visiting Us At ASAP AOG! Before You Go, Why Not Take a Look at Our Aircraft Parts Catalog? You Can Get One of the Most Competitive Quotes On the Market In 15 Minutes Or Less.
Request for QuotePart Number NDC00591-3213-72 having (CAGE Code 6LMB8) and FSC in stock with ready to ship. Get an instant quote for NDC00591-3213-72 Fentanyl Transdermal System by Actavis Pharma Inc. Fill the form below with your desired order quantity, targeted price and the expected order-fulfilment date. Our dedicated account manager will get back to you within 15 minutes.
ASAP AOG is a eminent NDC00591-3213-72 aircraft parts supplier to OEM, repair depot and other aviation sector. We are open for 7 days a week, 24 hours a day with instant Aircraft on Ground Support. All bill of materials can be sent via email to sales@asapaog.com in an excel format. Please feel free to call us at +1-714-705-4780.
| NSN | FSC | NIIN | CLS | Hazmat | DEMIL | Cancelled NSN |
|---|---|---|---|---|---|---|
| 6505-01-656-4667 Item Description: Fentanyl Transdermal System | 6505 | 016564667 | M | P | ||
| CIIC | HCC | ESD | PMIC | Criticality | ENAC | |
| R | A | 0 | ||||
| Part Number | ISC | RNVC | RNCC | HCC | MSDS | SADC |
| Ndc00591-3213-72 | 5 | 2 | 3 |
| MRC | Criteria | Characteristic |
|---|---|---|
| FEAT | Special Features | ROUTE: TRANSDERMAL; DOSE FORM: PATCH, TRANSDERMAL 72 HOURS; STRENGTH: 75 MCG/HOUR; DEA CONTROLLED II SUBSTANCE; INDIVIDUALLY SEALED; CONTAINS FIVE (75 MCG/HR) TRANSDERMAL SYSTEMS; STORE IN ORIGINAL UNOPENED POUCH. STORE UP TO 20 C TO 25 C (68 F TO 77 F; STRICT ADHERENCE TO THE RECOMMENDED HANDLING AND DISPOSAL INSTRUCTIONS ON PRODUCT INSERT IS OF THE UTMOST IMPORTANCE TO PREVENT ACCIDENTAL EXPOSURE; EXPOSURE OF FENTANYL TRANSDERMAL SYSTEM APPLICATION SITE AND SURROUNDING AREA TO DIRECT EXTERNAL HEAT SOURCES, SUCH AS HEATING PADS, SAUNAS, HOT TUBS AND HEATED WATER BEDS MAY INCREASE FENTANYL ABSORPTION AND RESULT IN FATAL OVERDOSE OF FENTANYL AND DEATH; PATIENTS WHO DEVELOP FEVER OR INCREASED CORE BODY TEMPERATURE DUE TO STRENOUS EXERTION ARE ALSO AT RISK FOR INCREASED FENTANYL EXPOSURE AND MAY REQUIRE AN ADJUSTMENT IN THE DOSE OF FENTANYL TRANSDERMAL SYSTEM TO AVOID OVERDOSE |
| CSLZ | Usual Dose | 75 MCG/HR |
| CBBL | Features Provided | INDIVIDUALLY SEALED |
| CRYC | Controlled Substance Classification | SCHEDULE II |
| CXCY | Part Name Assigned By Controlling Agency | DURAGESIC-75 (FENTANYL TRANSDERMAL SYSTEM) 75MCG/HR, 5S |
| MRC | Decoded Requirement | Clear Text Reply |
